Ivabradine for Heart Rate Control In Septic Shock

PHASE3RecruitingINTERVENTIONAL
Enrollment

429

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

September 24, 2024

Study Completion Date

December 24, 2024

Conditions
Septic Shock
Interventions
DRUG

Ivabradine

Ivabradine will be administered via the enteral route, every 12 hours, at doses ranging from 2.5 to 5 mg to achieve a target heart rate between 80 and 94 bpm

DRUG

Ivabradine

Ivabradine will be administered via the enteral route, every 12 hours, at doses ranging from 5 to 7.5 mg to achieve a target heart rate between 80 and 94

DRUG

Placebo

Placebo will be administered via the enteral route, every 12 hours.

Trial Locations (1)

94000

RECRUITING

Henri Mondor Hospital, Créteil

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04031573 - Ivabradine for Heart Rate Control In Septic Shock | Biotech Hunter | Biotech Hunter